HEADER HYDROLASE 07-JUN-14 4TPK TITLE HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H- TITLE 2 INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE CAVEAT 4TPK NAG A 608 HAS WRONG CHIRALITY AT C1 NAG A 607 HAS WRONG CAVEAT 2 4TPK CHIRALITY AT C1 NAG B 610 HAS WRONG CHIRALITY AT C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINESTERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ACYLCHOLINE ACYLHYDROLASE,BUTYRYLCHOLINE ESTERASE,CHOLINE COMPND 5 ESTERASE II,PSEUDOCHOLINESTERASE; COMPND 6 EC: 3.1.1.8; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCHE, CHE1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS BUTYRYLCHOLINESTERASE INHIBITION, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.COQUELLE,B.BRUS,J.P.COLLETIER,S.GOBEC REVDAT 2 29-JUL-20 4TPK 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 22-OCT-14 4TPK 0 JRNL AUTH B.BRUS,U.KOSAK,S.TURK,A.PISLAR,N.COQUELLE,J.KOS,J.STOJAN, JRNL AUTH 2 J.P.COLLETIER,S.GOBEC JRNL TITL DISCOVERY, BIOLOGICAL EVALUATION, AND CRYSTAL STRUCTURE OF A JRNL TITL 2 NOVEL NANOMOLAR SELECTIVE BUTYRYLCHOLINESTERASE INHIBITOR. JRNL REF J.MED.CHEM. V. 57 8167 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25226236 JRNL DOI 10.1021/JM501195E REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 40022 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.2025 - 5.6133 0.99 4538 140 0.1924 0.2347 REMARK 3 2 5.6133 - 4.4566 1.00 4356 133 0.1560 0.1871 REMARK 3 3 4.4566 - 3.8936 1.00 4346 136 0.1490 0.2021 REMARK 3 4 3.8936 - 3.5377 1.00 4305 136 0.1747 0.2366 REMARK 3 5 3.5377 - 3.2842 1.00 4279 132 0.1990 0.2548 REMARK 3 6 3.2842 - 3.0907 1.00 4233 135 0.2189 0.3258 REMARK 3 7 3.0907 - 2.9359 1.00 4278 126 0.2226 0.3001 REMARK 3 8 2.9359 - 2.8081 1.00 4257 133 0.2354 0.3050 REMARK 3 9 2.8081 - 2.7000 1.00 4228 131 0.2319 0.3154 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.380 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 9079 REMARK 3 ANGLE : 1.021 12288 REMARK 3 CHIRALITY : 0.038 1328 REMARK 3 PLANARITY : 0.005 1546 REMARK 3 DIHEDRAL : 14.508 3344 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TPK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000201991. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40037 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 46.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08829 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.390 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1POM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM ACETATE, 24% PEG 3350, REMARK 280 10 MM TRIS PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.30000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.82500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 115.82500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.30000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -27 REMARK 465 HIS A -26 REMARK 465 SER A -25 REMARK 465 LYS A -24 REMARK 465 VAL A -23 REMARK 465 THR A -22 REMARK 465 ILE A -21 REMARK 465 ILE A -20 REMARK 465 CYS A -19 REMARK 465 ILE A -18 REMARK 465 ARG A -17 REMARK 465 PHE A -16 REMARK 465 LEU A -15 REMARK 465 PHE A -14 REMARK 465 TRP A -13 REMARK 465 PHE A -12 REMARK 465 LEU A -11 REMARK 465 LEU A -10 REMARK 465 LEU A -9 REMARK 465 CYS A -8 REMARK 465 MET A -7 REMARK 465 LEU A -6 REMARK 465 ILE A -5 REMARK 465 GLY A -4 REMARK 465 LYS A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 THR A 0 REMARK 465 GLU A 1 REMARK 465 ASP A 2 REMARK 465 GLU A 531 REMARK 465 MET A 532 REMARK 465 THR A 533 REMARK 465 GLY A 534 REMARK 465 ASN A 535 REMARK 465 ILE A 536 REMARK 465 ASP A 537 REMARK 465 GLU A 538 REMARK 465 ALA A 539 REMARK 465 GLU A 540 REMARK 465 TRP A 541 REMARK 465 GLU A 542 REMARK 465 TRP A 543 REMARK 465 LYS A 544 REMARK 465 ALA A 545 REMARK 465 GLY A 546 REMARK 465 PHE A 547 REMARK 465 HIS A 548 REMARK 465 ARG A 549 REMARK 465 TRP A 550 REMARK 465 ASN A 551 REMARK 465 ASN A 552 REMARK 465 TYR A 553 REMARK 465 MET A 554 REMARK 465 MET A 555 REMARK 465 ASP A 556 REMARK 465 TRP A 557 REMARK 465 LYS A 558 REMARK 465 ASN A 559 REMARK 465 GLN A 560 REMARK 465 PHE A 561 REMARK 465 ASN A 562 REMARK 465 ASP A 563 REMARK 465 TYR A 564 REMARK 465 THR A 565 REMARK 465 SER A 566 REMARK 465 LYS A 567 REMARK 465 LYS A 568 REMARK 465 GLU A 569 REMARK 465 SER A 570 REMARK 465 CYS A 571 REMARK 465 VAL A 572 REMARK 465 GLY A 573 REMARK 465 LEU A 574 REMARK 465 MET B -27 REMARK 465 HIS B -26 REMARK 465 SER B -25 REMARK 465 LYS B -24 REMARK 465 VAL B -23 REMARK 465 THR B -22 REMARK 465 ILE B -21 REMARK 465 ILE B -20 REMARK 465 CYS B -19 REMARK 465 ILE B -18 REMARK 465 ARG B -17 REMARK 465 PHE B -16 REMARK 465 LEU B -15 REMARK 465 PHE B -14 REMARK 465 TRP B -13 REMARK 465 PHE B -12 REMARK 465 LEU B -11 REMARK 465 LEU B -10 REMARK 465 LEU B -9 REMARK 465 CYS B -8 REMARK 465 MET B -7 REMARK 465 LEU B -6 REMARK 465 ILE B -5 REMARK 465 GLY B -4 REMARK 465 LYS B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 THR B 0 REMARK 465 GLU B 1 REMARK 465 ASP B 2 REMARK 465 ASP B 3 REMARK 465 GLN B 484 REMARK 465 ASN B 485 REMARK 465 GLU B 531 REMARK 465 MET B 532 REMARK 465 THR B 533 REMARK 465 GLY B 534 REMARK 465 ASN B 535 REMARK 465 ILE B 536 REMARK 465 ASP B 537 REMARK 465 GLU B 538 REMARK 465 ALA B 539 REMARK 465 GLU B 540 REMARK 465 TRP B 541 REMARK 465 GLU B 542 REMARK 465 TRP B 543 REMARK 465 LYS B 544 REMARK 465 ALA B 545 REMARK 465 GLY B 546 REMARK 465 PHE B 547 REMARK 465 HIS B 548 REMARK 465 ARG B 549 REMARK 465 TRP B 550 REMARK 465 ASN B 551 REMARK 465 ASN B 552 REMARK 465 TYR B 553 REMARK 465 MET B 554 REMARK 465 MET B 555 REMARK 465 ASP B 556 REMARK 465 TRP B 557 REMARK 465 LYS B 558 REMARK 465 ASN B 559 REMARK 465 GLN B 560 REMARK 465 PHE B 561 REMARK 465 ASN B 562 REMARK 465 ASP B 563 REMARK 465 TYR B 564 REMARK 465 THR B 565 REMARK 465 SER B 566 REMARK 465 LYS B 567 REMARK 465 LYS B 568 REMARK 465 GLU B 569 REMARK 465 SER B 570 REMARK 465 CYS B 571 REMARK 465 VAL B 572 REMARK 465 GLY B 573 REMARK 465 LEU B 574 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 255 CG CD OE1 OE2 REMARK 470 TYR A 282 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 506 CG CD OE1 OE2 REMARK 470 LEU A 530 CA C O CB CG CD1 CD2 REMARK 470 ILE B 4 CG1 CG2 CD1 REMARK 470 LYS B 51 CG CD CE NZ REMARK 470 SER B 53 OG REMARK 470 TYR B 282 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN B 486 CG OD1 ND2 REMARK 470 SER B 507 CB OG REMARK 470 LEU B 530 CA C O CB CG CD1 CD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE B 4 O REMARK 480 SER B 53 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 341 C1 NAG F 1 1.41 REMARK 500 ND2 ASN B 481 C1 NAG B 610 1.46 REMARK 500 ND2 ASN B 17 O5 NAG B 601 1.61 REMARK 500 ND2 ASN A 341 O5 NAG F 1 1.64 REMARK 500 ND2 ASN B 256 O5 NAG B 608 1.66 REMARK 500 O4 NAG D 1 O5 NAG D 2 1.74 REMARK 500 ND2 ASN B 106 O5 NAG I 1 1.79 REMARK 500 ND2 ASN A 481 O5 NAG G 1 1.92 REMARK 500 ND2 ASN A 241 O5 NAG E 1 1.94 REMARK 500 C6 NAG F 1 C1 FUC F 3 2.01 REMARK 500 ND2 ASN B 57 C2 NAG B 602 2.03 REMARK 500 CG ASN B 256 C1 NAG B 608 2.04 REMARK 500 ND2 ASN A 486 O5 NAG H 1 2.07 REMARK 500 ND2 ASN A 106 O5 NAG D 1 2.13 REMARK 500 O4 NAG G 1 O5 NAG G 2 2.13 REMARK 500 CG ASN B 17 C1 NAG B 601 2.14 REMARK 500 OE1 GLU A 80 O HOH A 714 2.15 REMARK 500 CG ASN A 241 C1 NAG E 1 2.16 REMARK 500 CG ASN A 486 C1 NAG H 1 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 237 O ARG B 453 1565 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PHE A 364 CZ PHE A 364 CE2 -0.118 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 50 -98.63 -92.37 REMARK 500 ASP A 54 -167.49 104.36 REMARK 500 SER A 89 148.39 -170.27 REMARK 500 ASN A 106 48.86 -153.14 REMARK 500 ALA A 162 75.00 -159.38 REMARK 500 SER A 198 -117.91 65.89 REMARK 500 TYR A 282 -104.98 -71.00 REMARK 500 ASP A 297 -71.79 -127.16 REMARK 500 SER A 362 175.35 -58.11 REMARK 500 ARG A 381 80.73 46.85 REMARK 500 PHE A 398 -56.08 -126.98 REMARK 500 GLU A 482 -82.07 -105.53 REMARK 500 PHE B 43 -2.29 74.85 REMARK 500 ASP B 54 -138.09 -85.66 REMARK 500 SER B 89 148.50 -172.60 REMARK 500 ASN B 106 43.88 -145.10 REMARK 500 ALA B 162 78.74 -162.94 REMARK 500 SER B 198 -111.85 63.00 REMARK 500 TYR B 282 54.70 -90.93 REMARK 500 ASP B 297 -71.35 -136.92 REMARK 500 PHE B 398 -60.40 -127.26 REMARK 500 PRO B 480 44.77 -78.03 REMARK 500 GLU B 506 -73.41 -70.49 REMARK 500 PHE B 525 -52.40 -127.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG F 1 REMARK 610 NAG B 607 REMARK 610 NAG B 610 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BDS RELATED DB: PDB REMARK 900 4BDS IS THE SAME PROTEIN COMPLEXED WITH TACRINE DBREF 4TPK A -27 574 UNP P06276 CHLE_HUMAN 1 602 DBREF 4TPK B -27 574 UNP P06276 CHLE_HUMAN 1 602 SEQRES 1 A 602 MET HIS SER LYS VAL THR ILE ILE CYS ILE ARG PHE LEU SEQRES 2 A 602 PHE TRP PHE LEU LEU LEU CYS MET LEU ILE GLY LYS SER SEQRES 3 A 602 HIS THR GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY SEQRES 4 A 602 LYS VAL ARG GLY MET ASN LEU THR VAL PHE GLY GLY THR SEQRES 5 A 602 VAL THR ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO SEQRES 6 A 602 LEU GLY ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR SEQRES 7 A 602 LYS TRP SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SEQRES 8 A 602 SER CYS CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE SEQRES 9 A 602 HIS GLY SER GLU MET TRP ASN PRO ASN THR ASP LEU SER SEQRES 10 A 602 GLU ASP CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO SEQRES 11 A 602 LYS PRO LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY SEQRES 12 A 602 GLY GLY PHE GLN THR GLY THR SER SER LEU HIS VAL TYR SEQRES 13 A 602 ASP GLY LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL SEQRES 14 A 602 VAL SER MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU SEQRES 15 A 602 ALA LEU PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY SEQRES 16 A 602 LEU PHE ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS SEQRES 17 A 602 ASN ILE ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR SEQRES 18 A 602 LEU PHE GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU SEQRES 19 A 602 HIS LEU LEU SER PRO GLY SER HIS SER LEU PHE THR ARG SEQRES 20 A 602 ALA ILE LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA SEQRES 21 A 602 VAL THR SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN SEQRES 22 A 602 LEU ALA LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR SEQRES 23 A 602 GLU ILE ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU SEQRES 24 A 602 ILE LEU LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR SEQRES 25 A 602 PRO LEU SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP SEQRES 26 A 602 PHE LEU THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY SEQRES 27 A 602 GLN PHE LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS SEQRES 28 A 602 ASP GLU GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY SEQRES 29 A 602 PHE SER LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU SEQRES 30 A 602 PHE GLN GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER SEQRES 31 A 602 GLU PHE GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP SEQRES 32 A 602 TRP VAL ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA SEQRES 33 A 602 LEU GLY ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO SEQRES 34 A 602 ALA LEU GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN SEQRES 35 A 602 ASN ALA PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS SEQRES 36 A 602 LEU PRO TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR SEQRES 37 A 602 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG SEQRES 38 A 602 ASP ASN TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER SEQRES 39 A 602 ILE VAL LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN SEQRES 40 A 602 PRO ASN GLU THR GLN ASN ASN SER THR SER TRP PRO VAL SEQRES 41 A 602 PHE LYS SER THR GLU GLN LYS TYR LEU THR LEU ASN THR SEQRES 42 A 602 GLU SER THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN SEQRES 43 A 602 CYS ARG PHE TRP THR SER PHE PHE PRO LYS VAL LEU GLU SEQRES 44 A 602 MET THR GLY ASN ILE ASP GLU ALA GLU TRP GLU TRP LYS SEQRES 45 A 602 ALA GLY PHE HIS ARG TRP ASN ASN TYR MET MET ASP TRP SEQRES 46 A 602 LYS ASN GLN PHE ASN ASP TYR THR SER LYS LYS GLU SER SEQRES 47 A 602 CYS VAL GLY LEU SEQRES 1 B 602 MET HIS SER LYS VAL THR ILE ILE CYS ILE ARG PHE LEU SEQRES 2 B 602 PHE TRP PHE LEU LEU LEU CYS MET LEU ILE GLY LYS SER SEQRES 3 B 602 HIS THR GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY SEQRES 4 B 602 LYS VAL ARG GLY MET ASN LEU THR VAL PHE GLY GLY THR SEQRES 5 B 602 VAL THR ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO SEQRES 6 B 602 LEU GLY ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR SEQRES 7 B 602 LYS TRP SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SEQRES 8 B 602 SER CYS CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE SEQRES 9 B 602 HIS GLY SER GLU MET TRP ASN PRO ASN THR ASP LEU SER SEQRES 10 B 602 GLU ASP CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO SEQRES 11 B 602 LYS PRO LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY SEQRES 12 B 602 GLY GLY PHE GLN THR GLY THR SER SER LEU HIS VAL TYR SEQRES 13 B 602 ASP GLY LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL SEQRES 14 B 602 VAL SER MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU SEQRES 15 B 602 ALA LEU PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY SEQRES 16 B 602 LEU PHE ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS SEQRES 17 B 602 ASN ILE ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR SEQRES 18 B 602 LEU PHE GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU SEQRES 19 B 602 HIS LEU LEU SER PRO GLY SER HIS SER LEU PHE THR ARG SEQRES 20 B 602 ALA ILE LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA SEQRES 21 B 602 VAL THR SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN SEQRES 22 B 602 LEU ALA LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR SEQRES 23 B 602 GLU ILE ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU SEQRES 24 B 602 ILE LEU LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR SEQRES 25 B 602 PRO LEU SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP SEQRES 26 B 602 PHE LEU THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY SEQRES 27 B 602 GLN PHE LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS SEQRES 28 B 602 ASP GLU GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY SEQRES 29 B 602 PHE SER LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU SEQRES 30 B 602 PHE GLN GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER SEQRES 31 B 602 GLU PHE GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP SEQRES 32 B 602 TRP VAL ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA SEQRES 33 B 602 LEU GLY ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO SEQRES 34 B 602 ALA LEU GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN SEQRES 35 B 602 ASN ALA PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS SEQRES 36 B 602 LEU PRO TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR SEQRES 37 B 602 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG SEQRES 38 B 602 ASP ASN TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER SEQRES 39 B 602 ILE VAL LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN SEQRES 40 B 602 PRO ASN GLU THR GLN ASN ASN SER THR SER TRP PRO VAL SEQRES 41 B 602 PHE LYS SER THR GLU GLN LYS TYR LEU THR LEU ASN THR SEQRES 42 B 602 GLU SER THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN SEQRES 43 B 602 CYS ARG PHE TRP THR SER PHE PHE PRO LYS VAL LEU GLU SEQRES 44 B 602 MET THR GLY ASN ILE ASP GLU ALA GLU TRP GLU TRP LYS SEQRES 45 B 602 ALA GLY PHE HIS ARG TRP ASN ASN TYR MET MET ASP TRP SEQRES 46 B 602 LYS ASN GLN PHE ASN ASP TYR THR SER LYS LYS GLU SER SEQRES 47 B 602 CYS VAL GLY LEU HET NAG C 1 14 HET FUL C 2 10 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET FUC E 2 10 HET NAG F 1 14 HET NAG F 2 14 HET FUC F 3 10 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET NAG I 1 14 HET NAG I 2 14 HET NAG J 1 14 HET FUL J 2 10 HET NAG A 601 14 HET 3F9 A 615 33 HET GOL A 616 6 HET EDO A 617 4 HET EDO A 618 4 HET NAG B 601 14 HET NAG B 602 14 HET NAG B 607 14 HET NAG B 608 14 HET NAG B 609 14 HET NAG B 610 14 HET 3F9 B 611 33 HET GOL B 612 6 HET GOL B 613 6 HET GOL B 614 6 HET GOL B 615 6 HET EDO B 616 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM 3F9 N-{[(3R)-1-(2,3-DIHYDRO-1H-INDEN-2-YL)PIPERIDIN-3- HETNAM 2 3F9 YL]METHYL}-N-(2-METHOXYETHYL)NAPHTHALENE-2-CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETSYN FUL 6-DEOXY-BETA-L-GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 20(C8 H15 N O6) FORMUL 3 FUL 2(C6 H12 O5) FORMUL 5 FUC 2(C6 H12 O5) FORMUL 12 3F9 2(C29 H34 N2 O2) FORMUL 13 GOL 5(C3 H8 O3) FORMUL 14 EDO 3(C2 H6 O2) FORMUL 28 HOH *172(H2 O) HELIX 1 AA1 LEU A 38 ARG A 42 5 5 HELIX 2 AA2 PHE A 76 MET A 81 1 6 HELIX 3 AA3 LEU A 125 ASP A 129 5 5 HELIX 4 AA4 GLY A 130 ARG A 138 1 9 HELIX 5 AA5 GLY A 149 LEU A 154 1 6 HELIX 6 AA6 ASN A 165 ILE A 182 1 18 HELIX 7 AA7 ALA A 183 PHE A 185 5 3 HELIX 8 AA8 SER A 198 SER A 210 1 13 HELIX 9 AA9 SER A 210 SER A 215 1 6 HELIX 10 AB1 SER A 235 THR A 250 1 16 HELIX 11 AB2 ASN A 256 ARG A 265 1 10 HELIX 12 AB3 ASP A 268 LEU A 274 1 7 HELIX 13 AB4 ASN A 275 VAL A 280 5 6 HELIX 14 AB5 MET A 302 LEU A 309 1 8 HELIX 15 AB6 GLY A 326 VAL A 331 1 6 HELIX 16 AB7 THR A 346 PHE A 358 1 13 HELIX 17 AB8 SER A 362 TYR A 373 1 12 HELIX 18 AB9 GLU A 383 PHE A 398 1 16 HELIX 19 AC1 PHE A 398 GLU A 411 1 14 HELIX 20 AC2 PRO A 431 GLY A 435 5 5 HELIX 21 AC3 GLU A 441 PHE A 446 1 6 HELIX 22 AC4 GLY A 447 ASN A 455 5 9 HELIX 23 AC5 THR A 457 GLY A 478 1 22 HELIX 24 AC6 ARG A 515 PHE A 525 1 11 HELIX 25 AC7 PHE A 526 VAL A 529 5 4 HELIX 26 AC8 LEU B 38 ARG B 42 5 5 HELIX 27 AC9 PHE B 76 MET B 81 1 6 HELIX 28 AD1 LEU B 125 ASP B 129 5 5 HELIX 29 AD2 GLY B 130 ARG B 138 1 9 HELIX 30 AD3 GLY B 149 LEU B 154 1 6 HELIX 31 AD4 ASN B 165 ILE B 182 1 18 HELIX 32 AD5 ALA B 183 PHE B 185 5 3 HELIX 33 AD6 SER B 198 SER B 210 1 13 HELIX 34 AD7 PRO B 211 PHE B 217 5 7 HELIX 35 AD8 SER B 235 THR B 250 1 16 HELIX 36 AD9 ASN B 256 ARG B 265 1 10 HELIX 37 AE1 ASP B 268 LEU B 274 1 7 HELIX 38 AE2 ASN B 275 VAL B 280 5 6 HELIX 39 AE3 MET B 302 GLY B 310 1 9 HELIX 40 AE4 GLY B 326 VAL B 331 1 6 HELIX 41 AE5 THR B 346 PHE B 358 1 13 HELIX 42 AE6 SER B 362 TYR B 373 1 12 HELIX 43 AE7 GLU B 383 PHE B 398 1 16 HELIX 44 AE8 PHE B 398 GLU B 411 1 14 HELIX 45 AE9 PRO B 431 GLY B 435 5 5 HELIX 46 AF1 GLU B 441 PHE B 446 1 6 HELIX 47 AF2 GLY B 447 ASN B 455 5 9 HELIX 48 AF3 THR B 457 GLY B 478 1 22 HELIX 49 AF4 ARG B 515 PHE B 525 1 11 HELIX 50 AF5 PHE B 526 VAL B 529 5 4 SHEET 1 AA1 3 ILE A 5 THR A 8 0 SHEET 2 AA1 3 GLY A 11 ARG A 14 -1 O VAL A 13 N ILE A 6 SHEET 3 AA1 3 ILE A 55 ASN A 57 1 O TRP A 56 N ARG A 14 SHEET 1 AA211 MET A 16 VAL A 20 0 SHEET 2 AA211 GLY A 23 PRO A 32 -1 O ALA A 27 N MET A 16 SHEET 3 AA211 TYR A 94 ALA A 101 -1 O LEU A 95 N ILE A 31 SHEET 4 AA211 ILE A 140 MET A 144 -1 O SER A 143 N ASN A 96 SHEET 5 AA211 ALA A 107 ILE A 113 1 N LEU A 110 O ILE A 140 SHEET 6 AA211 GLY A 187 GLU A 197 1 O ASN A 188 N ALA A 107 SHEET 7 AA211 ARG A 219 GLN A 223 1 O ILE A 221 N LEU A 194 SHEET 8 AA211 ILE A 317 ASN A 322 1 O LEU A 318 N LEU A 222 SHEET 9 AA211 ALA A 416 PHE A 421 1 O PHE A 417 N VAL A 319 SHEET 10 AA211 LYS A 499 LEU A 503 1 O LEU A 503 N TYR A 420 SHEET 11 AA211 ILE A 510 THR A 512 -1 O MET A 511 N TYR A 500 SHEET 1 AA3 3 ILE B 5 THR B 8 0 SHEET 2 AA3 3 GLY B 11 ARG B 14 -1 O GLY B 11 N THR B 8 SHEET 3 AA3 3 ILE B 55 ASN B 57 1 O TRP B 56 N LYS B 12 SHEET 1 AA411 MET B 16 VAL B 20 0 SHEET 2 AA411 GLY B 23 PRO B 32 -1 O VAL B 25 N LEU B 18 SHEET 3 AA411 TYR B 94 ALA B 101 -1 O VAL B 97 N PHE B 28 SHEET 4 AA411 ILE B 140 MET B 144 -1 O SER B 143 N ASN B 96 SHEET 5 AA411 ALA B 107 ILE B 113 1 N TRP B 112 O VAL B 142 SHEET 6 AA411 GLY B 187 GLU B 197 1 O THR B 193 N VAL B 109 SHEET 7 AA411 ARG B 219 GLN B 223 1 O ILE B 221 N LEU B 194 SHEET 8 AA411 ILE B 317 ASN B 322 1 O LEU B 318 N LEU B 222 SHEET 9 AA411 ALA B 416 PHE B 421 1 O PHE B 417 N VAL B 319 SHEET 10 AA411 LYS B 499 LEU B 503 1 O LEU B 503 N TYR B 420 SHEET 11 AA411 ILE B 510 THR B 512 -1 O MET B 511 N TYR B 500 SSBOND 1 CYS A 65 CYS A 92 1555 1555 2.04 SSBOND 2 CYS A 252 CYS A 263 1555 1555 2.04 SSBOND 3 CYS A 400 CYS A 519 1555 1555 2.06 SSBOND 4 CYS B 65 CYS B 92 1555 1555 2.05 SSBOND 5 CYS B 252 CYS B 263 1555 1555 2.05 SSBOND 6 CYS B 400 CYS B 519 1555 1555 2.06 LINK ND2 ASN A 17 C1 NAG A 601 1555 1555 1.49 LINK ND2 ASN A 57 C1 NAG C 1 1555 1555 1.47 LINK ND2 ASN A 106 C1 NAG D 1 1555 1555 1.42 LINK ND2 ASN A 241 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN A 481 C1 NAG G 1 1555 1555 1.41 LINK ND2 ASN A 486 C1 NAG H 1 1555 1555 1.45 LINK ND2 ASN B 17 C1 NAG B 601 1555 1555 1.48 LINK ND2 ASN B 57 C1 NAG B 602 1555 1555 1.47 LINK ND2 ASN B 106 C1 NAG I 1 1555 1555 1.44 LINK ND2 ASN B 241 C1 NAG J 1 1555 1555 1.44 LINK ND2 ASN B 256 C1 NAG B 608 1555 1555 1.46 LINK ND2 ASN B 341 C1 NAG B 609 1555 1555 1.49 LINK O6 NAG C 1 C1 FUL C 2 1555 1555 1.42 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.46 LINK O6 NAG E 1 C1 FUC E 2 1555 1555 1.46 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.41 LINK O6 NAG F 1 C1 FUC F 3 1555 1555 1.46 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.47 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.45 LINK O4 NAG I 1 C1 NAG I 2 1555 1555 1.49 LINK O6 NAG J 1 C1 FUL J 2 1555 1555 1.49 CISPEP 1 ALA A 101 PRO A 102 0 4.37 CISPEP 2 GLN A 380 ARG A 381 0 -4.58 CISPEP 3 ALA B 101 PRO B 102 0 4.37 CRYST1 76.600 80.200 231.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013055 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012469 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004317 0.00000